top of page
Kiren Sehmi BSc. (Hons.) FBDO CL
3 min read
Clinical Peer-Reviewed Article Summary
Lotilaner Ophthalmic Solution(TP-03), 0.25%, for the Treatment of Demodex Blepharitis: A Randomized, Double-Masked, Vehicle-Controlled,...
Kiren Sehmi BSc. (Hons.) FBDO CL
1 min read
A Clinical Drug Intervention Presentation
Welcome to the drug intervention presentation for TP-03, a novel ophthalmic solution that offers hope to patients suffering from Demodex...
Kiren Sehmi BSc. (Hons.) FBDO CL
3 min read
Eyes On Vaping
Vaping is an increasingly popular trend, but you may be underestimating its impact on your patients’ health. You know that it’s harmful,...
Grow Your Vision With A Tailored Approach
bottom of page